CIK 0002020932 · Non-accelerated filer<br>Emerging growth company
AgomAb Therapeutics NV
Sign in to watch- Ticker
- AGMB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Belgium
- Entity type
- other
- Phone
- 32 3 302 35 30
- Business address
- POSTHOFLEI 1/6, ANTWERPEN, Belgium, 2600
- Open-market buys, last 90 days
- $592,149
- in 7 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$592,149. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-13 | Epstein David R Director | Purchase | +5,000 | $5.99 | $30K | 45,000 |
| 2026-11-13 | Epstein David R Director | Purchase | +20 | $6.00 | $120 | 45,020 |
| 2026-11-13 | Epstein David R Director | Purchase | +5,000 | $5.75 | $29K | 50,020 |
| 2026-11-13 | Epstein David R Director | Purchase | +4,960 | $6.02 | $30K | 54,980 |
| 2026-11-05 | Epstein David R Director | Purchase | +5,000 | $6.81 | $34K | 30,000 |
| 2026-11-05 | Epstein David R Director | Purchase | +5,000 | $6.91 | $35K | 35,000 |
| 2026-11-05 | Epstein David R Director | Purchase | +5,000 | $6.98 | $35K | 40,000 |
| 2026-10-21 | Epstein David R Director | Purchase | +5,000 | $8.86 | $44K | 20,000 |
| 2026-10-21 | Epstein David R Director | Purchase | +5,000 | $8.90 | $45K | 25,000 |
| 2026-10-08 | Epstein David R Director | Purchase | +5,000 | $8.90 | $45K | 15,000 |
| 2026-10-06 | Epstein David R Director | Purchase | +5,000 | $8.70 | $44K | 10,000 |
| 2026-10-05 | Epstein David R Director | Purchase | +5,000 | $8.57 | $43K | 5,000 |
Page 1 of 1 · 12 trades